[PDF] Top 20 Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion
Has 10000 "Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion" found on our website. Below are the top 20 most common "Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion".
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion
... 35% of the cases, has been reported to be associated with poorer survival [ 10 ...size of the deletion affecting the 13q14 region has been suggested to determine differences in ... Voir le document complet
7
Long non-coding RNAs as molecular signatures for canine B-Cell lymphoma characterization
... Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in ... Voir le document complet
12
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort
... analysis, and their correlation with PET scan imaging by ...complement with previously published results obtained from tumor biopsies from patients enrolled in LYSA clinical trials, we ... Voir le document complet
14
Gene expression-based risk score in diffuse large B-cell lymphoma.
... use large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma and displays heterogeneous clinical and molecular ...proiling of DLBCL ... Voir le document complet
12
Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044
... Introduction Diffuse large B- cell lymphoma (DLBCL) is a common aggressive malignancy of mature B cells, accounting for 30–40% of adult non- Hodgkin’s lymphoma ... Voir le document complet
18
Role of ETS1 in the transcriptional network of diffuse large B cell lymphoma of the activated B cell-like type
... Abstract: Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease that has been distinguished into at least two major molecular entities, the germinal center-like B ... Voir le document complet
17
Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
... expression of IL-35 in human ...type of non- Hodgkin lymphoma among adults, diffuse large B-cell lymphoma (DLBCL), but not in another type of mature aggressive ... Voir le document complet
13
A new diagnostic algorithm for Burkitt and diffuse large B-cell lymphomas based on the expression of CSE1L and STAT3 and on MYC rearrangement predicts outcome
... finition of these two entities incorporates clinical information, histomorphology, immunohistochemistry, as well as genetic alterations including BCL2, BCL6, and MYC ...translocations. With the ... Voir le document complet
9
Regulatory myeloid cells: an underexplored continent in B-cell lymphomas
... In B-cell lymphomas, the myeloid compartment contributes to prognosis Lymphomas constitute a large group of cancer arising from lymphoid or extra- nodal tissues ...nomenclature ... Voir le document complet
26
Clinical and molecular characterization of 17q21.31 microdeletion syndrome in 14 French patients with mental retardation.
... diagnosis of mental retardation through the use of a “reverse phenotyping” approach making it possible to identify recurrent genomic rearrangements before their clinical description ...recent ... Voir le document complet
28
Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma
... splenic B cell lymphomas, the splenic diffuse red pulp lymphoma with villous lymphocytes (SDRPL) has been identified as an entity close to but distinct from SMZL ...different ... Voir le document complet
11
Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
... progression and leading to growth arrest. The majority of DLBCLs have a structural basis for increased E2F1-mediated cell cycle progression; however, these tumors may differ in BRD4 super-loading ... Voir le document complet
29
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
... comprehensive characterization of a series of 673 CL BCs collected though a meta-analysis of public gene expression ...literature, with nearly 9-fold more samples than in the pioneering ... Voir le document complet
15
Comprehensive molecular characterization of clear cell renal cell carcinoma
... a large network of genes and pathways (larger implicated network in Supplementary ...circle with various levels of data, plotted such that each ‘spoke’ in the ring represents a single ... Voir le document complet
8
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma Patients
... vaccination and adoptive T cell transfer with chimeric T cell receptors ...One of the CTAs under intense investigation is the Sp17 ...testis and its reported expression ... Voir le document complet
10
Primary bone diffuse large B-cell lymphoma: a retrospective evaluation on 76 cases from French institutional and LYSA studies
... characteristics of patients from PBL and LNH03 cohorts are provided in Table 1 ...males and 29 ...(42%) and disseminated (stage IV) in 44 (58%) ...(36%) and unavailable for 4 ...(CG) ... Voir le document complet
8
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
... funding Oncosuisse (ICP OCS-01356-03-2003). acknowledgements The following members of the IELSG (listed in alphabetical order) contributed patients to the study: O. Bairey, Rabin Medical Centre, Beilinson Campus, ... Voir le document complet
9
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
... 7 of 23 Results Basal phosphorylation levels distinguish lymphoma types To investigate basal phosphorylation levels across B-NHL, we included patient samples from DLBCL, FL, MCL and CLL (Supplemental ... Voir le document complet
31
Diffuse large B-cell lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA).
... 55% of WR DLBCLs were classified as centroblastic, 39% as centroblastic polymorphous, 3% as immunoblastic, and 3% ...Among large biopsy specimens (n=79), 18% had a prominent nodular ... Voir le document complet
1
Diffuse Large B-cell Lymphomas of the waldeyer's ring frequently have a germinal center-like phenotype: a clinico-pathological study of 209 patients from the groupe d'étude des lymphomes de l'adulte (GELA).
... Laurence de Leval, MD 1,2 , Christophe Bonnet, MD 2,3,* , Christiane Copie-Bergman, MD 2,4,* , Laurence Seidel, PhD 5,* , Josette Brière, MD 2,* , Thierry Molina, MD 2,* , Bettina Fabiani, MD 2,* , Brunangelo Falini, MD ... Voir le document complet
2
Sujets connexes